1342 related articles for article (PubMed ID: 15740494)
1. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt in nonliver transplant candidates: is it indicated?
Spiess SE; Matalon TA; Jensen DM; Rosenblate HJ; Brunner MC; Ganger DR
Am J Gastroenterol; 1995 Aug; 90(8):1238-43. PubMed ID: 7639222
[TBL] [Abstract][Full Text] [Related]
4. Surgical shunts and TIPS for variceal decompression in the 1990s.
Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D
Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086
[TBL] [Abstract][Full Text] [Related]
5. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt: an analysis of outcomes.
Kurmis TP
ANZ J Surg; 2009 Oct; 79(10):745-9. PubMed ID: 19878172
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
8. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
[TBL] [Abstract][Full Text] [Related]
9. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
[TBL] [Abstract][Full Text] [Related]
11. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
12. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
13. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.
Chen L; Xiao T; Chen W; Long Q; Li R; Fang D; Wang R
Liver Int; 2009 Aug; 29(7):1101-9. PubMed ID: 19386025
[TBL] [Abstract][Full Text] [Related]
15. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
[TBL] [Abstract][Full Text] [Related]
16. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
Harrod-Kim P; Saad WE; Waldman D
J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
[TBL] [Abstract][Full Text] [Related]
17. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score.
Trotter JF; Suhocki PV; Rockey DC
Am J Gastroenterol; 1998 Oct; 93(10):1891-4. PubMed ID: 9772050
[TBL] [Abstract][Full Text] [Related]
19. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
Monescillo A; Martínez-Lagares F; Ruiz-del-Arbol L; Sierra A; Guevara C; Jiménez E; Marrero JM; Buceta E; Sánchez J; Castellot A; Peñate M; Cruz A; Peña E
Hepatology; 2004 Oct; 40(4):793-801. PubMed ID: 15382120
[TBL] [Abstract][Full Text] [Related]
20. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period.
Gaba RC; Omene BO; Podczerwinski ES; Knuttinen MG; Cotler SJ; Kallwitz ER; Berkes JL; Walzer NM; Bui JT; Owens CA
J Vasc Interv Radiol; 2012 Feb; 23(2):227-35. PubMed ID: 22178037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
